Fighting Antibiotic Resistance
Antibiotics are highly efficient drugs to kill pathogenic bacteria with low side effects. For more than 70 years, the massive use of these miracle drugs has saved millions of human and animal lives. Unfortunately […]
Le projet EBO-SURSY est financé par l’Union Européenne (UE) à hauteur de 8 millions d’euros. Il a été lancé le 15 janvier 2017 dans 10 pays prioritaires pour une période de 5 ans. […]
Molecular epidemiology and immuno-biology of malaria transmission stages
Description: This 4-year group (G4) at Centre Pasteur Cameroon is focused on understanding the dynamics of malaria transmission stages (gametocyte stages) and their interactions with different host immune systems. Plasmodium gametocytes are the only […]
Human enterovirus a71 circulation and epidemic risk in cameroon: characterization and pathogenicity of new viral genogroups
Description: The human Enterovirus A71 (EV-A71) belong to the species Enterovirus A, within the family Picornaviridae. EV-A71 circulates worldwide causing disease primarily among children. EV-A71 is associated to major outbreak of Hand-Foot-Mouth Disease characterized […]
Prevalence and virologic characterization of HIV-1 M and HIV-1 O dual infections and VIH-1 M+O recombinant forms associated, or not to a dual infection, circulating in Cameroon
Description: The Human Immunodeficiency Virus type 1 (HIV-1) genetic diversity includes four groups: M (major), O (outlier), N (non-M- non O) and P. HIV-1 groups M and O co-circulate in Cameroon where dual infections […]
Factors favouring the emergence of vaccine-derived polioviruses: search for enteroviruses that recombine with poliovirus
Description: Outbreaks of poliomyelitis caused by pathogenic circulating vaccine-derived polioviruses (cVDPVs) have been reported in different tropical countries including Madagascar, Nigeria, Chad and Democratic Republic of Congo (DR Congo). Most cVDPVs implicated in polio […]
Phylogenomics of Shiga’s epidemic dysentery bacillus (Shigella dysenteriae type 1)
The agent of epidemic dysentery, the bacterium Shigella dysenteriae type 1, was isolated in Japan in 1897 by Dr Kyoshi Shiga during a massive epidemic of bloody diarrhea that caused 20,000 deaths over a […]
Enterovirus A 71 (EV-A71) is an emerging pathogen that is circulating worldwide and mostly causes hand, foot, and mouth disease (HFMD) in children. However, in many cases, EV-A71 causes neurological complications, such as meningitis, […]
The European Virus Archive Goes Global
The European Virus Archive now goes global and become EVAg as a continuation of EVA within the Horizon 2020 programme .The new EVAg consortium (25 institution from 19 countries, EU and non-EU ) is […]
A multi-disciplinary study of human beings, great apes, and viral emergence in equatorial Africa (SHAPES)
This multi-disciplinary study examines the changing nature and contexts of human contact with great apes and monkeys in equatorial Africa and the health consequences of that contact. Biomedical researchers have scrutinized the nature of […]
REEMFOAMY : Human infection with zoonotic simian foamy retroviruses: role of virological and immunological factors in restricting viral emergence
The public health relevance of retroviruses of zoonotic origin is illustrated by the human immunodeficiency virus (HIV) epidemic, the worldwide distribution of human T-lymphotropic viruses (HTLVs), and the morbidity and mortality associated with both […]
PreCASA (Pre-Antiretroviral Therapy Cryptococcal Antigen Screening in AIDS) is a prospective cohort study in Yaounde, Cameroon on severely immunosuppressed HIV-infected patients entering the local antiretroviral therapy (ART) program at less than 100 CD cell […]
Epidemiology of Buruli ulcer in Cameroon
Funding: ANR, Fondation Raoul Follereau, Fondation SANOFI Espoir. In this new research program, we will conduct for the first time the simultaneous collection of environmental (plants and insects) and human samples in two […]
Clinical trial on cryptococcosis « ACTA »
A Medical Research Council and France Recherche Nord & Sud Sida-hiv Hepatites (ANRS) funded trial supervised by Tom Harrison (UK) with Olivier Lortholary being principal investigator “north” for Cameroon sites is being implemented in Malawi, […]
Tuberculosis Research Laboratory
Description: Tuberculosis (TB) is one of the oldest known human diseases and is a major cause of morbidity worldwide. Projects are focused on several approaches: – Drug discovery from phenotypic, infected macrophages assay – […]
Alerting and Surveillance for Infectious Disease Epidemics
Description: Enhance global health security and advance International Health Regulations (2005) implementation by sustaining and strengthening preparedness, detection, and communication capacities for pandemic influenza and emerging and re-emerging infectious diseases in Sub-Saharan African and […]
InPRIS : Building and strengthening core capacities for Influenza Preparedness and Response in Support of International Health Regulations (IHR 2005)
Description: According to the World health Organization (WHO), influenza viruses are responsible for about 3 to 5 million severe cases of respiratory diseases, Influenza Like Illness (ILI) and Severe Acute Respiratory Infections (SARI) leading […]
2018Genetic Characterization of Enterovirus A71 Circulating in Africa, Emerg Infect Dis. 2018;24(4):754-757.
2016Whole Genome Sequencing of Enterovirus species C Isolates by High-throughput Sequencing: Development of Generic Primers, Front. Microbiol. 7:1294.
2014Characterization of Enteroviruses from non-human primates in cameroon revealed virus types widespread in humans along with candidate new types and species, PLoS Negl Trop Dis 2014;8(7):e3052.
2012High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries, J. Clin. Microbiol. 2013 Mar;51(3):759-70.
2007Chikungunya virus, Cameroon, 2006, Emerging Infect. Dis. 2007 May;13(5):768-71.
+View full list of publications
Location: Pasteur Center in Cameroon, B.P. 1274, Yaoundé, Cameroon